173 related articles for article (PubMed ID: 34463913)
1. Systematic Analysis of Cytostatic TGF-Beta Response in Mesenchymal-Like Hepatocellular Carcinoma Cell Lines.
Gungor MZ; Uysal M; Ozturk M; Senturk S
J Gastrointest Cancer; 2021 Dec; 52(4):1320-1335. PubMed ID: 34463913
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
Dzieran J; Fabian J; Feng T; Coulouarn C; Ilkavets I; Kyselova A; Breuhahn K; Dooley S; Meindl-Beinker NM
PLoS One; 2013; 8(8):e72252. PubMed ID: 23991075
[TBL] [Abstract][Full Text] [Related]
3. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ
PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
[TBL] [Abstract][Full Text] [Related]
4. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1.
Zhang Y; Shi K; Liu H; Chen W; Luo Y; Wei X; Wu Z
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):554-562. PubMed ID: 32324847
[TBL] [Abstract][Full Text] [Related]
5. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
Yan X; Wu J; Jiang Q; Cheng H; Han JJ; Chen YG
J Mol Cell Biol; 2018 Feb; 10(1):48-59. PubMed ID: 29036306
[TBL] [Abstract][Full Text] [Related]
6. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
[TBL] [Abstract][Full Text] [Related]
8. KLF2 inhibits TGF-β-mediated cancer cell motility in hepatocellular carcinoma.
Li Y; Tu S; Zeng Y; Zhang C; Deng T; Luo W; Lian L; Chen L; Xiong X; Yan X
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):485-494. PubMed ID: 32318691
[TBL] [Abstract][Full Text] [Related]
9. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
Liu Z; Zhang Y; Xu Z
J BUON; 2018; 23(1):188-192. PubMed ID: 29552782
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
11. Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma.
Wan ZH; Ma YH; Jiang TY; Lin YK; Shi YY; Tan YX; Dong LW; Wang HY
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):525-531. PubMed ID: 31564506
[TBL] [Abstract][Full Text] [Related]
12. Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells.
Wittmann P; Grubinger M; Gröger C; Huber H; Sieghart W; Peck-Radosavljevic M; Mikulits W
BMC Cancer; 2015 Nov; 15():909. PubMed ID: 26573807
[TBL] [Abstract][Full Text] [Related]
13. Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma.
Feng T; Dzieran J; Gu X; Marhenke S; Vogel A; Machida K; Weiss TS; Ruemmele P; Kollmar O; Hoffmann P; Grässer F; Allgayer H; Fabian J; Weng HL; Teufel A; Maass T; Meyer C; Lehmann U; Zhu C; Mertens PR; Gao CF; Dooley S; Meindl-Beinker NM
Clin Sci (Lond); 2015 Jun; 128(11):761-74. PubMed ID: 25602745
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.
Chen J; Zaidi S; Rao S; Chen JS; Phan L; Farci P; Su X; Shetty K; White J; Zamboni F; Wu X; Rashid A; Pattabiraman N; Mazumder R; Horvath A; Wu RC; Li S; Xiao C; Deng CX; Wheeler DA; Mishra B; Akbani R; Mishra L
Gastroenterology; 2018 Jan; 154(1):195-210. PubMed ID: 28918914
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
[TBL] [Abstract][Full Text] [Related]
16. TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling.
Park SA; Kim MJ; Park SY; Kim JS; Lim W; Nam JS; Yhong Sheen Y
Sci Rep; 2015 Nov; 5():16492. PubMed ID: 26549110
[TBL] [Abstract][Full Text] [Related]
17. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma.
Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sakitani K; Yamashiki N; Seki T; Saito H; Nishizawa M; Fujisawa J; Inoue K
Cancer Res; 2000 Mar; 60(5):1394-402. PubMed ID: 10728705
[TBL] [Abstract][Full Text] [Related]
18. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
[TBL] [Abstract][Full Text] [Related]
19. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
